248 related articles for article (PubMed ID: 9373789)
21. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
[TBL] [Abstract][Full Text] [Related]
22. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
23. Cefepime: a review of its use in the management of hospitalized patients with pneumonia.
Chapman TM; Perry CM
Am J Respir Med; 2003; 2(1):75-107. PubMed ID: 14720024
[TBL] [Abstract][Full Text] [Related]
24. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
Chin NX; Neu HC
Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of cefepime, a new parenteral cephalosporin, against recent European blood isolates and in comparison with piperacillin/tazobactam.
Dornbusch K; Mörtsell E; Göransson E
Chemotherapy; 1990; 36(4):259-67. PubMed ID: 2174761
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
King A; Boothman C; Phillips I
Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):677-85. PubMed ID: 2226498
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
Jones RN; Marshall SA
Diagn Microbiol Infect Dis; 1994 May; 19(1):33-8. PubMed ID: 7956010
[TBL] [Abstract][Full Text] [Related]
28. In-vitro activity of BMY 28142, a new aminothiazolyl cephalosporin.
Steele JC; Edwards BH; Rissing JP
J Antimicrob Chemother; 1985 Oct; 16(4):463-8. PubMed ID: 3840799
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
[TBL] [Abstract][Full Text] [Related]
30. [Sensitivity to antibiotics of bacteria from nosocomial infections. Evolution in resuscitation services of military hospitals].
Garrabé E; Cavallo JD; Brisou P; Chapalain JC; Coué JC; Courrier P; Granic G; Hervé V; Koeck JL; Morillon M; Claude JD; Rouby Y; Teyssou R
Presse Med; 2000 Sep; 29(27):1497-503. PubMed ID: 11045115
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
Vurma-Rapp U; Kayser FH; Barberis-Maino L
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():27-33. PubMed ID: 3102452
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of cefepime and other broad-spectrum beta-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study Group.
Biedenbach DJ; Lewis MT; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):277-83. PubMed ID: 10668586
[TBL] [Abstract][Full Text] [Related]
33. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
34. [In vitro study of antibacterial activity of cefepime (Axepim) against gram negative bacteria: comparison with cephalosporins and other beta-lactams].
Vachée A; Devalckenaere A; Husson MO; Izard D
Pathol Biol (Paris); 1996 Feb; 44(2):132-7. PubMed ID: 8761598
[TBL] [Abstract][Full Text] [Related]
35. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
Aldridge KE; Henderberg A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
[TBL] [Abstract][Full Text] [Related]
36. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
Triantafilo V; Fica A; Silva M; Thompson L
Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934
[TBL] [Abstract][Full Text] [Related]
37. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
Bell JM; Turnidge JD;
Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of cefdinir (FK 482, PD 134393, CI-983): a new orally active cephalosporin.
Qadri SM; Ueno Y; Saldin H; Cunha BA
Chemotherapy; 1993; 39(2):112-9. PubMed ID: 8458243
[TBL] [Abstract][Full Text] [Related]
39. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
